IL-6 could discriminate tuberculosis patients with and without unfavorable treatment outcomes with an AUC of 0.69 (95%CI 0.55-0.85) for all participants and 0.66 (95%CI 0.42-0.85) when restricted to HIV coinfected participants (Figure-4). This evidence concerns the gene IL6 and tuberculosis.